Zentalis Pharmaceuticals Number Of Shares Shorted vs. Shares Outstanding
| ZNTL Stock | USD 3.61 0.02 0.55% |
For Zentalis Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Zentalis Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Zentalis Pharmaceuticals Llc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Zentalis Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Zentalis Pharmaceuticals Llc over time as well as its relative position and ranking within its peers.
Zentalis |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis Pharmaceuticals. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.50) | Revenue Per Share 0.572 | Return On Assets (0.25) | Return On Equity (0.43) |
The market value of Zentalis Pharmaceuticals is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zentalis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zentalis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zentalis Pharmaceuticals Shares Outstanding vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Zentalis Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Zentalis Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Zentalis Pharmaceuticals Llc is rated below average in number of shares shorted category among its peers. It is rated below average in shares outstanding category among its peers creating about 14.35 of Shares Outstanding per Number Of Shares Shorted. The value of Common Stock Shares Outstanding is expected to slide to about 46.9 M. Comparative valuation analysis is a catch-all technique that is used if you cannot value Zentalis Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Zentalis Shares Outstanding vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Zentalis Pharmaceuticals |
| = | 4.97 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Zentalis Pharmaceuticals |
| = | 71.27 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Zentalis Shares Outstanding Comparison
Zentalis Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.
Zentalis Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Zentalis Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Zentalis Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Zentalis Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Zentalis Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.2 M | 2.3 M | |
| Net Interest Income | 572.7 K | 469.1 K | |
| Interest Income | 572.7 K | 469.1 K | |
| Operating Income | -249 M | -236.5 M | |
| Net Loss | -286.4 M | -272 M | |
| Income Before Tax | -276.9 M | -263 M | |
| Total Other Income Expense Net | -27.9 M | -26.5 M | |
| Net Loss | -213.1 M | -202.5 M | |
| Net Loss | -292.2 M | -277.6 M | |
| Income Tax Expense | -601 K | -571 K | |
| Non Operating Income Net Other | -14.7 M | -13.9 M | |
| Change To Netincome | 71.8 M | 75.4 M | |
| Net Loss | (4.47) | (4.69) | |
| Income Quality | 0.71 | 0.90 | |
| Net Income Per E B T | 1.06 | 0.79 |
Zentalis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Zentalis Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Zentalis Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Zentalis Pharmaceuticals' important profitability drivers and their relationship over time.
Use Zentalis Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zentalis Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Zentalis Pharmaceuticals Pair Trading
Zentalis Pharmaceuticals Llc Pair Trading Analysis
The ability to find closely correlated positions to Zentalis Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zentalis Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zentalis Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zentalis Pharmaceuticals Llc to buy it.
The correlation of Zentalis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zentalis Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zentalis Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zentalis Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Zentalis Pharmaceuticals position
In addition to having Zentalis Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
To fully project Zentalis Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Zentalis Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Zentalis Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.